Literature DB >> 31591157

Biallelic Mutations in TSC2 Lead to Abnormalities Associated with Cortical Tubers in Human iPSC-Derived Neurons.

Kellen D Winden1, Maria Sundberg1, Cindy Yang2, Syed M A Wafa2, Sean Dwyer2, Pin-Fang Chen2, Elizabeth D Buttermore2, Mustafa Sahin3,2.   

Abstract

Tuberous sclerosis complex (TSC) is a genetic disorder caused by mutations in TSC1 or TSC2 Patients frequently have epilepsy, autism spectrum disorder, and/or intellectual disability, as well as other systemic manifestations. In this study, we differentiated human induced pluripotent stem cells (iPSCs) from a female patient with TSC with one or two mutations in TSC2 into neurons using induced expression of NGN2 to examine neuronal dysregulation associated with the neurological symptoms in TSC. Using this method, neuronal differentiation was comparable between the three genotypes of iPSCs. We observed that TSC2 +/- neurons show mTOR complex 1 (mTORC1) hyperactivation and associated increased cell body size and process outgrowth, as well as exacerbation of the abnormalities by loss of the second allele of TSC2 in TSC2 -/- neurons. Interestingly, iPSC-derived neurons with either a single or biallelic mutation in TSC2 demonstrated hypersynchrony and downregulation of FMRP targets. However, only neurons with biallelic mutations of TSC2 demonstrated hyperactivity and transcriptional dysregulation observed in cortical tubers. These data demonstrate that loss of one allele of TSC2 is sufficient to cause some morphological and physiological changes in human neurons but that biallelic mutations in TSC2 are necessary to induce gene expression dysregulation present in cortical tubers. Finally, we found that treatment of iPSC-derived neurons with rapamycin reduced neuronal activity and partially reversed gene expression abnormalities, demonstrating that mTOR dysregulation contributes to both phenotypes. Therefore, biallelic mutations in TSC2 and associated molecular dysfunction, including mTOR hyperactivation, may play a role in the development of cortical tubers.SIGNIFICANCE STATEMENT In this study, we examined neurons derived from induced pluripotent stem cells with two, one, or no functional TSC2 (tuberous sclerosis complex 2) alleles and found that loss of one or both alleles of TSC2 results in mTORC1 hyperactivation and specific neuronal abnormalities. However, only biallelic mutations in TSC2 resulted in elevated neuronal activity and upregulation of cell adhesion genes that is also observed in cortical tubers. These data suggest that loss of heterozygosity of TSC1 or TSC2 may play an important role in the development of cortical tubers, and potentially epilepsy, in patients with TSC.
Copyright © 2019 the authors.

Entities:  

Keywords:  FMRP; TSC2; cortical tuber; iPSC; mTOR; tuberous sclerosis

Mesh:

Substances:

Year:  2019        PMID: 31591157      PMCID: PMC6867816          DOI: 10.1523/JNEUROSCI.0642-19.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  50 in total

1.  Biallelic TSC gene inactivation in tuberous sclerosis complex.

Authors:  Peter B Crino; Eleonora Aronica; Gordon Baltuch; Katherine L Nathanson
Journal:  Neurology       Date:  2010-05-25       Impact factor: 9.910

2.  Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex.

Authors:  B Patel; J Patel; J-H Cho; S Manne; S Bonala; E Henske; F Roegiers; M Markiewski; M Karbowniczek
Journal:  Oncogene       Date:  2015-10-05       Impact factor: 9.867

Review 3.  Molecular neurobiology of mTOR.

Authors:  Katarzyna Switon; Katarzyna Kotulska; Aleksandra Janusz-Kaminska; Justyna Zmorzynska; Jacek Jaworski
Journal:  Neuroscience       Date:  2016-11-23       Impact factor: 3.590

4.  Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features.

Authors:  Elizabeth Yuan; Peter T Tsai; Emily Greene-Colozzi; Mustafa Sahin; David J Kwiatkowski; Izabela A Malinowska
Journal:  Hum Mol Genet       Date:  2012-06-29       Impact factor: 6.150

5.  Neural progenitors derived from Tuberous Sclerosis Complex patients exhibit attenuated PI3K/AKT signaling and delayed neuronal differentiation.

Authors:  Avery J Zucco; Valentina Dal Pozzo; Alina Afinogenova; Ronald P Hart; Orrin Devinsky; Gabriella D'Arcangelo
Journal:  Mol Cell Neurosci       Date:  2018-08-23       Impact factor: 4.314

6.  Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.

Authors:  Jacqueline A French; John A Lawson; Zuhal Yapici; Hiroko Ikeda; Tilman Polster; Rima Nabbout; Paolo Curatolo; Petrus J de Vries; Dennis J Dlugos; Noah Berkowitz; Maurizio Voi; Severine Peyrard; Diana Pelov; David N Franz
Journal:  Lancet       Date:  2016-09-06       Impact factor: 79.321

7.  Intrinsic epileptogenicity of cortical tubers revealed by intracranial EEG monitoring.

Authors:  Ahmad R Mohamed; Catherine A Bailey; Jeremy L Freeman; Wirginia Maixner; Graeme D Jackson; A Simon Harvey
Journal:  Neurology       Date:  2012-11-21       Impact factor: 9.910

8.  Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.

Authors:  Krinio Giannikou; Izabela A Malinowska; Trevor J Pugh; Rachel Yan; Yuen-Yi Tseng; Coyin Oh; Jaegil Kim; Magdalena E Tyburczy; Yvonne Chekaluk; Yang Liu; Nicola Alesi; Geraldine A Finlay; Chin-Lee Wu; Sabina Signoretti; Matthew Meyerson; Gad Getz; Jesse S Boehm; Elizabeth P Henske; David J Kwiatkowski
Journal:  PLoS Genet       Date:  2016-08-05       Impact factor: 5.917

9.  Abnormal Neural Progenitor Cells Differentiated from Induced Pluripotent Stem Cells Partially Mimicked Development of TSC2 Neurological Abnormalities.

Authors:  Yaqin Li; Jiqing Cao; Menglong Chen; Jing Li; Yiming Sun; Yu Zhang; Yuling Zhu; Liang Wang; Cheng Zhang
Journal:  Stem Cell Reports       Date:  2017-03-23       Impact factor: 7.765

10.  Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.

Authors:  N Lozovaya; S Gataullina; T Tsintsadze; V Tsintsadze; E Pallesi-Pocachard; M Minlebaev; N A Goriounova; E Buhler; F Watrin; S Shityakov; A J Becker; A Bordey; M Milh; D Scavarda; C Bulteau; G Dorfmuller; O Delalande; A Represa; C Cardoso; O Dulac; Y Ben-Ari; N Burnashev
Journal:  Nat Commun       Date:  2014-08-01       Impact factor: 14.919

View more
  24 in total

1.  Tuberous Sclerosis Complex (TSC) Inactivation Increases Neuronal Network Activity by Enhancing Ca2+ Influx via L-Type Ca2+ Channels.

Authors:  Chihiro Hisatsune; Tadayuki Shimada; Akitoshi Miyamoto; Amy Lee; Kanato Yamagata
Journal:  J Neurosci       Date:  2021-08-20       Impact factor: 6.167

Review 2.  Modeling tuberous sclerosis complex with human induced pluripotent stem cells.

Authors:  Weibo Niu; Benjamin Siciliano; Zhexing Wen
Journal:  World J Pediatr       Date:  2022-06-27       Impact factor: 9.186

Review 3.  Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications.

Authors:  Chen-Chen Jiang; Li-Shan Lin; Sen Long; Xiao-Yan Ke; Kohji Fukunaga; Ying-Mei Lu; Feng Han
Journal:  Signal Transduct Target Ther       Date:  2022-07-11

Review 4.  Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids.

Authors:  Aleksandr Shcheglovitov; Randall T Peterson
Journal:  Neurotherapeutics       Date:  2021-09-30       Impact factor: 6.088

Review 5.  Identification of TSC2 mosaic mutation limited to cortical tuber with TSC targeted sequencing: a case report and literature review.

Authors:  Yuanfeng Zhou; Xinhua Wang; Ji Wang; Yifeng Ding; Yi Wang; Hao Li; Rui Zhao; Bingbing Wu
Journal:  Childs Nerv Syst       Date:  2021-01-30       Impact factor: 1.475

6.  RHOA signaling defects result in impaired axon guidance in iPSC-derived neurons from patients with tuberous sclerosis complex.

Authors:  Timothy S Catlett; Massimo M Onesto; Alec J McCann; Sarah K Rempel; Jennifer Glass; David N Franz; Timothy M Gómez
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

7.  16p11.2 deletion is associated with hyperactivation of human iPSC-derived dopaminergic neuron networks and is rescued by RHOA inhibition in vitro.

Authors:  Hannah Pinson; Richard S Smith; Maria Sundberg; Kellen D Winden; Pooja Venugopal; Derek J C Tai; James F Gusella; Michael E Talkowski; Christopher A Walsh; Max Tegmark; Mustafa Sahin
Journal:  Nat Commun       Date:  2021-05-18       Impact factor: 14.919

Review 8.  Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex.

Authors:  Wardiya Afshar Saber; Mustafa Sahin
Journal:  Mol Autism       Date:  2020-02-19       Impact factor: 7.509

9.  Multimodal Analysis of STRADA Function in Brain Development.

Authors:  Louis T Dang; Katarzyna M Glanowska; Philip H Iffland Ii; Allan E Barnes; Marianna Baybis; Yu Liu; Gustavo Patino; Shivanshi Vaid; Alexandra M Streicher; Whitney E Parker; Seonhee Kim; Uk Yeol Moon; Frederick E Henry; Geoffrey G Murphy; Michael Sutton; Jack M Parent; Peter B Crino
Journal:  Front Cell Neurosci       Date:  2020-05-08       Impact factor: 5.505

Review 10.  Dysregulation of protein synthesis and dendritic spine morphogenesis in ASD: studies in human pluripotent stem cells.

Authors:  Louisa Hoi-Ying Lo; Kwok-On Lai
Journal:  Mol Autism       Date:  2020-05-27       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.